Walt Addison Linscott - 10 Apr 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Operating Officer
Signature
/s/ Walt Linscott
Issuer symbol
INDP
Transactions as of
10 Apr 2025
Net transactions value
-$502
Form type
4
Filing time
11 Apr 2025, 16:15:24 UTC
Previous filing
10 Oct 2024
Next filing
29 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Disposed to Issuer $103 -1,750 -100% $0.0590 0 10 Apr 2025 Common Stock 1,750 $684.80 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $44.25 -750 -100% $0.0590 0 10 Apr 2025 Common Stock 750 $684.80 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $73.75 -1,250 -100% $0.0590 0 10 Apr 2025 Common Stock 1,250 $25.72 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $66.38 -1,125 -100% $0.0590 0 10 Apr 2025 Common Stock 1,125 $34.32 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $148 -2,500 -100% $0.0590 0 10 Apr 2025 Common Stock 2,500 $72.00 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $66.38 -1,125 -100% $0.0590 0 10 Apr 2025 Common Stock 1,125 $610.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.